Your browser doesn't support javascript.
loading
AZD1080, a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans.
Georgievska, Biljana; Sandin, Johan; Doherty, James; Mörtberg, Anette; Neelissen, Jan; Andersson, Anita; Gruber, Susanne; Nilsson, Yvonne; Schött, Pär; Arvidsson, Per I; Hellberg, Sven; Osswald, Gunilla; Berg, Stefan; Fälting, Johanna; Bhat, Ratan V.
Affiliation
  • Georgievska B; AstraZeneca R&D, Innovative Medicines CNS and Pain, Södertälje, Sweden. georgievska_biljana@yahoo.se
J Neurochem ; 125(3): 446-56, 2013 May.
Article in En | MEDLINE | ID: mdl-23410232
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tau Proteins / Long-Term Potentiation / Glycogen Synthase Kinase 3 / Enzyme Inhibitors Type of study: Clinical_trials / Prognostic_studies Language: En Journal: J Neurochem Year: 2013 Document type: Article Affiliation country: Suecia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tau Proteins / Long-Term Potentiation / Glycogen Synthase Kinase 3 / Enzyme Inhibitors Type of study: Clinical_trials / Prognostic_studies Language: En Journal: J Neurochem Year: 2013 Document type: Article Affiliation country: Suecia